Advanced Biomedical Technologies, Inc.
ABMT · OTC
7/31/2022 | 4/30/2022 | 1/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | -$0 | -$0 | $0 | $0 |
| % Growth | -4,742.2% | -100% | 127.6% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | 147.6% | 6,584.3% | 85.6% | 73.4% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | 2,105% | 97,856.9% | 52.4% | -65.8% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | 3,842.6% | 186,752.9% | 20.6% | -137.1% |
| EPS Diluted | -0.003 | -0.003 | 0.001 | -0.002 |
| % Growth | 0% | -437.5% | 133.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |